Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.010
+0.080 (2.73%)
At close: Jan 31, 2025, 4:00 PM
3.020
+0.010 (0.33%)
After-hours: Jan 31, 2025, 4:57 PM EST
Mereo BioPharma Group Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$7.83
Upside
+160.13%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +132.56% | Jan 13, 2025 |
LifeSci Capital | LifeSci Capital | Buy Initiates $10 | Buy | Initiates | $10 | +232.23% | Dec 24, 2024 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +132.56% | Dec 17, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +132.56% | Dec 6, 2024 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +132.56% | Nov 12, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +132.56% | Oct 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +132.56% | Sep 16, 2024 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +132.56% | Aug 13, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +132.56% | Jul 22, 2024 |
Leerink Partners | Leerink Partners | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +165.78% | Jun 20, 2024 |
Baird | Baird | Buy Initiates $8 | Buy | Initiates | $8 | +165.78% | Jun 13, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +132.56% | Jun 12, 2024 |
Needham | Needham | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +132.56% | Jun 12, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +132.56% | May 16, 2024 |
Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +99.34% | May 16, 2024 |
Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +99.34% | Apr 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.